Science Immunology Submission Guide

Before choosing the journal, trace the claim through four links. The map is useful because immunology papers often look broad in the introduction but become descriptive at the decisive experiment.

The strongest package makes all four links visible in the abstract and first figures; it does not ask the cover letter to repair a missing mechanistic bridge.

• Submission intake: Reconcile the cover letter, abstract, figures, data-availability statement, and conflict declarations before upload.
• Editorial assessment: Make the immunology significance and Science-family fit visible in the abstract and first figure; AAAS decides whether the paper moves to review.
• Reviewer selection and review: If invited, reviewers test mechanism, experimental rigor, claim breadth, and whether the evidence travels beyond the immediate model.
• Decision and revision: Use the editor's letter to separate required evidence from presentation work, and answer every material point with a traceable change or response.

Run a Science Immunology pre-submission readiness check before clicking submit, or work through this guide manually.

Use this page if you're preparing a Science Immunology submission and want to understand the Science-family routing and how the journal differs from sister immunology venues.

We reviewed the Science Immunology page on AAAS, the AAAS submission guidance, and recent issues. The readiness interpretation below is Manusights editorial judgment applied to those public sources.

Before submitting to Science Immunology, a Science Immunology submission readiness check identifies whether the package meets the editorial bar before you commit to the submission.

Source limitations: official journal and publisher pages define scope, article types, and submission mechanics, but they do not publish manuscript-level desk decisions; the patterns below combine public guidance, recent issue review, and anonymized Manusights pre-submission review work.

Source: Science Immunology on AAAS, Clarivate 2026 JCR release, accessed April 2026.

The strategic implication: top-tier broadly-significant immunology fits Science (flagship); broadly-significant immunology with OA preference fits Science Advances; specialist top-tier immunology fits Science Immunology.

Three operational signals govern editorial assessment:

1. Immunology substance. The journal requires substantive immunology contribution.

2. Methodological rigor. Experimental, computational, or clinical immunology work must be top-tier.

3. Broad immunology relevance. The work should be of broad immunology-community interest.

Recent issues span:

• T-cell exhaustion and immunotherapy

• Cancer immunology and CAR-T

• mRNA vaccines and vaccine immunology

• Autoimmunity and tolerance mechanisms

• Mucosal immunology and gut-microbe interactions

• Viral immunology and antiviral responses

• Single-cell immunology

• Computational immunology and immune-cell atlases

For specific recent papers and DOIs, use the current issue list at Science Immunology on AAAS, because article metadata changes as online-first papers move into issues.

• Initial decision: use the current journal metric or manuscript record; no fixed duration is promised here

• First decision after review: varies with reviewer recruitment, report return, and editorial synthesis

• Revision rounds: follow the decision letter; count and scope vary by manuscript

• Time to publication after acceptance: weeks (online publication)

Those sources settle the mechanics. Whether the draft earns review is separate. The review tells you whether your paper clears the Science Immunology fit check before upload, especially around wrong Science-family venue chosen, wrong immunology venue chosen, and methodological execution doesn't clear top-tier bar. Paid Manusights reviews include a 60-day money-back guarantee, and we do not train models on submitted manuscripts.

Three patterns generate the most consistent rejections.

They are routing, evidence, and execution problems rather than formatting defects, and each becomes visible before a reviewer needs to read the full methods section.

Wrong Science-family venue chosen

Top-tier broadly-significant immunology fits Science; broadly-significant immunology with OA fits Science Advances; specialist immunology fits Science Immunology. In Manusights review work, this failure often appears in the first four artifacts: the abstract promises general-science consequence, Figure 1 shows a specialist immunology mechanism, the cover letter names a broad audience without explaining why that audience needs the paper, and the references benchmark against Nature Immunology or Immunity rather than AAAS Science-family papers.

The manuscript component that decides the route is usually not the title. It is whether the central figure and methods support a claim that matters across immunology subfields or across broader Science-family readership.

For Science Immunology specifically, informed routing means asking whether the paper is specialist but top-tier. A T-cell exhaustion paper with deep mechanistic experiments, orthogonal validation, and a figure package built around immunology consequence may fit Science Immunology. A paper claiming general biomedical consequence from one model system may need Science, Science Translational Medicine, or a narrower immunology venue depending on the actual evidence.

Check wrong science family venue chosen before submitting to Science Immunology →

Wrong immunology venue chosen

Science Immunology competes with Nature Immunology, Immunity, JEM, JCI, and Cell Host & Microbe. The recurring pattern is a manuscript whose experiments are strong but whose venue argument is generic: "important immunology" rather than "right for AAAS Science-family immunology." The abstract, cover letter, and first figure should show why an immunology specialist outside the immediate subfield will care. A cancer-immunology manuscript needs more than response-rate language; it needs immune-mechanism depth.

A mucosal-immunology paper needs more than microbiome association; it needs immune-cell, tissue, or mechanistic specificity. A computational immunology paper needs validation that immunologists, not only modelers, can trust.

This is also where the submission package can expose weakness. If the suggested reviewers all come from one narrow disease area, if the references skip competing top immunology papers, or if the Discussion reads like a specialty-journal argument, the editor may read the manuscript as misplaced even when the experiments are competent.

Check wrong immunology venue chosen before submitting to Science Immunology →

Methodological execution doesn't clear top-tier bar

The third pattern is methodological execution that does not clear the top-tier bar. The paper may have an interesting immune phenotype but weak causal depth, a single model system, underpowered patient samples, missing orthogonal validation, incomplete controls, or a Figure 1 that summarizes correlation rather than mechanism. Science Immunology editors and reviewers expect the methods, supplementary figures, reagent details, statistical plan, and data availability statement to support the central claim without requiring trust in the authors' narrative.

Before submission, stress-test the package component by component: abstract claim, Figure 1 mechanism, control figure, patient or model-system validation, methods reproducibility, data/code availability, and cover-letter venue argument. A Science Immunology manuscript readiness check can identify whether immunology framing, Science-family fit, and methodological rigor align before submission.

Check methodological execution doesn't clear top tier bar before submitting to Science Immunology →

• Is Science Immunology a good journal?

• Nature Immunology Submission Guide

• Nature Reviews Immunology Submission Guide

• Immunity Submission Guide

Submission caps: Science Immunology Research Articles cap at 6,000 to 8,000 words of main text with up to 8 figures or tables (5 to 8 typical); the abstract caps at 250 words (125 words ideal) and figure legends at 200 words each. The Materials and Methods section is uncapped but should be focused on reproducibility-critical experimental detail with reagent identifiers and statistical analysis plans. The title cannot exceed 135 characters including spaces.

Required sections are Abstract, Introduction, Results, Discussion, Materials and Methods, and References per the Science Immunology Instructions for Authors of Research Articles. Citations use the complete AAAS citation format including all authors, full article titles, journal abbreviation, volume, first-and-last page, and publication year. Submit through the AAAS unified submission system at AAAS journal page.

Frequently asked questions:

How long does Science Immunology take to review? Answer: The public guidance used for this page does not support one reliable promise for an individual manuscript. Editorial routing, reviewer recruitment, active review, revision, and production vary. Use the manuscript record and any current journal-level metric AAAS publishes.

What is the Science Immunology format and cover letter requirement? Answer: Manuscripts use the AAAS Science-family format. The cover letter must explain why the work fits Science Immunology specifically rather than Nature Immunology, Immunity, or specialty venues; AAAS editors use the cover letter to assess broad-immunology fit before sending for external review.

What is Science Immunology's desk rejection rate? Answer: The official pages reviewed for this guide do not provide a current manuscript-level desk-rejection denominator. The actionable screen is whether the immunology advance matters beyond one narrow system and whether the evidence supports that reach.

Is Science Immunology open access? What is the APC? Answer: Science Immunology offers an optional gold open-access pathway via Science Advances cross-publication; for the subscription track, no APC applies but author-paid open-access fees are available per AAAS open-access policy.

Or see example reports before you finalize.

The earlier first-read matrix identifies the editorial questions. This follow-up strengthens the most common scientific dependency: whether the paper observes an immune state, predicts an outcome, or establishes the mechanism that produces it.

Use the narrowest accurate verb in the title and abstract. This distinct repeat treatment addresses claim calibration rather than the August 17 editorial-screen artifact, and the overlapping measurement window will be labeled confounded.

Official sources accessed 2026-08-18.

Official and authoritative sources accessed 2026-08-17.

• Science Immunology on AAAS

• Science Immunology Instructions for Authors of Research Articles, AAAS.

• Clarivate 2026 JCR release (IF and ranking)

• AAAS Science journals editorial policies

Last verified: April 2026 against Science Immunology editorial pages.